揭示癌症中的衰老:机械复杂性和治疗机会
Prajakta Tiwari1, Shreesh Kumar Shukla1, Smita Rastogi Verma2
1Department of Biotechnology, Delhi Technological University, Delhi, 110042, India.
Molecular biology reports
|May 30, 2025
概括
细胞衰老,一个参与衰老和瘤抑制的过程,矛盾的是,通过其分泌表型促进癌症. 这篇评论探讨了衰老的过程.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 衰老研究研究 衰老研究
背景情况:
- 衰老是一种由压力因素引发的细胞状态,对发育,免疫力,组织修复和衰老至关重要.
- 它通过阻止细胞循环而起瘤抑制作用,但长期衰老可以矛盾地推动癌症的进展.
- 癌细胞中与衰老相关的分泌表型 (SASP) 促进了癌细胞的增殖,入侵和转移.
研究的目的:
- 阐明衰老在癌症抑制和进展中的分子机制.
- 审查诱导衰老的传统和新兴癌症疗法.
- 突出 senotherapeutic 策略和机器学习在瘤学中的应用.
主要方法:
- 关于癌症衰老的综合文献综述.
- 对调节衰老的分子通路的分析.
- 检查针对衰老的治疗策略.
- 讨论用于生物标志物发现和患者分层的机器学习.
主要成果:
- 衰老可以通过诱导生长停止和增强免疫监测来抑制癌症.
- 长期衰老和SASP可以促进瘤发生和转移.
- 传统和新型疗法可以诱导衰老;老年疗法提供有针对性的方法.
- 机器学习有助于识别衰老生物标志物和分层癌症患者.
结论:
- 衰老在癌症中扮演着双重的角色,既可以作为抑制剂,也可以作为促进剂.
- 针对衰老,特别是衰老细胞,具有显著的治疗前景.
- 将机器学习与衰老研究相结合,可以彻底改变癌症治疗的有效性.
关键词:
机器学习 机器学习衰老是一种衰老.与衰老相关的分泌表现型以衰老为目标的癌症治疗疗法Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals Senocidals鼻疗法 (Senotherapy) 是一种鼻疗法.相关概念视频
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Replicative Cell Senescence
4.3K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


